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Response of plasma triglycerides to dietary change in patients on
hemodialysis. The effect of reduction in dietary carbohydrate con-
tent of meal formula diets on plasma triglyceride concentrations
was studied in 12 patients receiving chronic hemodialysis. Fasting
plasma triglycerides decreased over a 10-day period in II of 12
patients in response to a decreased proportion of carbohydrate
(from 50 to 35% of total daily calories) regardless of the type of fat
used. Postprandial insulin responses were also signilicantly lower
in the patients on the diets lower in carbohydrate. In addition,
triglyceride kinetics were studied in three groups of patients.
Patients with renal failure (dialyzed and undialyzed) had lower
triglyceride production rates than those of control subjects, despite
higher plasma triglyceride concentrations. Elevated (>150 mgIlOO
ml) fasting plasma triglycerides are associated with lower triglycer-
ide production rates in patients with chronic renal failure and may
not be improved by conventional hemodialysis. A long-term study
of the efficacy of reduction in dietary carbohydrate on plasma
triglycerides is needed since routine hemodialysis does not appear
to correct the lipid abnormality in patients with chronic renal
failure.
Réponse des triglycerides plasmatiques aux modifications du
régime chez les malades en hémodlalyse. L'effet de Ia diminution
du contenu en hydrates de carbone de l'alimentation sur les con-
centrations des triglycerides plasmatiques a été étudié chez 12
malades soumis a l'hémodialyse chronique. Les triglycerides plas-
matiques, mesurés àjeun, ont diminué sur une période de lOjours
chez 11 des 12 malades en réponse a une diminution de Ia proper-
tion d'hydrates de carbone (de 50 a 35% de l'apport calonque
quotidien) indépendamment de Ia catégorie de graisse utilisée. Les
reponses insuliniques post-prandiales sont significativement dimi-
nuCes chez les malades recevant I'alimentation restreinte en hy-
drates de carbone. De plus, Ia cinétique des triglycerides a été
étudióe dans trois groupes de malades. Les malades atteints
d'insuffisance rénale (dialyses ou non dialyses) oat un debit de
production de triglycerides inférieur a celui des sujets témoins
malgré une concentration plasmatique supérieure. Des concentra-
tions de triglycerides élevées (superieures a 150 mg/lOO ml) àjeun
sont associées a des debits de production de triglycerides bas chez
les malades en insuffisance rénale et cette hypertriglycéridémie
peut ne pas étre améliorée par l'hemodialyse. Une étude au long
cours de l'efflcacité de Ia diminution des hydrates de carbone
alimentaires sur l'hypertriglycendemie est nécessaire puisque
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lhemodialyse conventionnelle ne parait pas corriger t'anomalie
lipidique chez les malades en insuffisance rénale.
We and others have previously shown that ele-
vated concentrations of plasma triglycerides are
commonly seen in patients with chronic renal failure
prior to the development of end-stage disease [1, 2].
Measurement of triglyceride kinetics in our patients
indicated that the hypertriglyceridemia occurred at
relatively low triglyceride production rates, suggest-
ing that a defect in triglyceride removal was respon-
sible for the rise in plasma triglyceride concentra-
tions. On the other hand, it was possible to lower
plasma triglycerides by dietary changes that led to
decreases in triglyceride production rate. Thus, these
results indicated that the development of hypertri-
glyceridemia in patients with chronic renal failure
might be modified by dietary intervention, without
producing any fundamental change in the responsible
abnormality of triglyceride kinetics. Although these
results provided potentially important clinical infor-
mation, they left unanswered at least two relevant
questions. First, it remained to be determined
whether the same dietary modifications that were
effective in patients with chronic renal failure before
the development of end-stage disease would produce
similar results in patients on chronic dialysis. Sec-
ond, the diet used to lower plasma triglycerides fea-
tured both a reduction in total carbohydrate content
and an increase in the polyunsaturated to saturated
fat ratio. Since both of these changes have been
reported to lead to a fall in triglyceride concentra-
tions [1, 3—5], it was impossible to know which
component of the diet was most responsible for the
changes observed. The present studies were under-
taken in an effort to answer these two questions, as
well as to clarify the effect of chronic hemodialysis
on the relationship between triglyceride production
rate and plasma triglyceride concentrations.
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Methods
Patients. Twelve male patients with end-stage re-
nal disease who had received chronic intermittent
hemodialysis for at least 6 months prior to study
were selected from the hemodialysis units at the Palo
Alto Veterans Administration Hospital and the Stan-
ford Satellite Dialysis Center. None of the patients
were receiving insulin, prednisone, or lipid-lowering
agents. Androgenic steroids were discontinued in all
patients 2 weeks prior to study. Patients with recent
myocardial infarction or cerebrovascular accident,
uncontrolled hypertension, or serum albumin less
than 3.0 g/100 ml were excluded. Selection was made
without regard to a history of lipid abnormalities.
Protocol. Patients were admitted to the Stanford
General Clinical Research Center and assigned to
one of two isocaloric formula (liquid) diets. Formula
diets were used to facilitate controlled metabolic
studies. Patients were fed 35 calories/kg of body wt
per day, and the diets were given as one-fifth of total
daily calories at 8 A.M., two-fifths at noon, and two-
fifths at 5 P.M. Weights were stable throughout the
study.
One diet, the "conventional diet," was designed
to simulate the diet that most patients would likely
eat at home. It contained 10% of the total calories as
protein, 50% as carbohydrate, and 40% as fats. Cho-
lesterol content was 600 mg/day. Polyunsaturated-to-
saturated fat ratio was 0.2. A second diet, the "low-
carbohydrate polyunsaturated fat diet," also con-
tained 10% of total calories as protein. The carbohy-
drate content, however, was reduced from 50% to
35%. To maintain caloric balance, fat content was
increased from 40 to 55%, but the type of fat was
changed to yield a polyunsaturated-to-saturated fat
ratio of 2.0. In addition, the cholesterol content was
reduced to 300 mg/day. Thus, the second diet was
low in carbohydrate and cholesterol and relatively
high in polyunsaturated fat. Eight patients were stud-
ied on the conventional and low-carbohydrate poly-
unsaturated fat (low-CHO PSF) diets. In an effort to
demonstrate which component of the diet might be
most responsible for any changes observed, four
additional patients were placed alternately on the
conventional and a "low-carbohydrate saturated
fat" diet. Like the conventional diet, the low-carbo-
hydrate saturated fat (low-CHO SF) diet contained
600 mg/day of cholesterol and a polyunsaturated-to-
satu rated fat ratio of 0.2. The proportion of carbohy-
drate, however, was decreased to 35% with concom-
itant increase in fat to 55% (see Table 1). Contents of
sucrose, sodium, and potassium were identical in all
three diets.
A single-blind crossover design was used. That is,
Table 1. Composition of the three isocaloric diets
Low- Low-
carbohydrate carbohydrate
Conventional polyunsaturated saturated fat
diet fat diet diet
Protein, %total
calories per
day 10 10 10
Carbohydrate, %
total calories
per day 50 35 35
Fat, % total
calories per
day 40 55 55
P:S ratioa 0.2 2.0 0.2
Cholesterol, rng/
day 600 300 600
a P:S is the p01yunsaturated-to-saturated fat ratio.
patient no. I began on the conventional diet. After a
10-day period, he switched to either the low-carbo-
hydrate polyunsaturated fat diet or the low-carbohy-
drate saturated fat diet. Patient no. 2 began on either
the low-carbohydrate polyunsaturated fat diet or the
low-carbohydrate saturated fat diet, then switched to
the conventional diet. Three times per week, hemo-
dialysis treatments continued uninterrupted during
the entire period of study. No patients were using
glucose-containing dialysate. All studies were con-
ducted on nondialysis days. In addition, coordina-
tion of the dialysis and testing schedule for each
patient was such as to approximate similar levels of
azotemia at the time of each meal tolerance test. The
following determinations were made during the 10-
day dietary periods: I) fasting plasma glucose, insu-
lin, triglyceride, and cholesterol concentrations were
measured on days 7, 8, and 10 of each dietary period;
2) meal tolerance tests were performed on days 8 and
10 of each dietary period. These consisted of measur-
ing glucose, insulin, and triglyceride concentrations
in response to the lunch meal. For this purpose, a
blood sample was taken just prior to ingestion of the
noon meal, and again at 1, 2, and 3 P.M. Other
studies in our laboratory support the reliability of this
time period for evaluating postprandial lipemia [61.
Nine male patients similar to the study group in
age, weight, and duration of hemodialysis and fulfill-
ing all of the above criteria for selection were studied
separately along with 13 male volunteers of compara-
ble age and weight and normal renal function in order
to determine the relationship between triglyceride
concentration and turnover rate. All 22 subjects had
been on the conventional diet for 9 days prior to
study. On day 10 an injection of 300 Ci of tritium-
labeled glycerol was given i.v. at 8 A.M.. Subjects
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received one-twelfth of the day's formula at 2 P.M.
and 5 P.M. to maintain constant plasma triglyceride
levels. Blood samples were drawn at 10 A.M., 11
A.M., noon, 2 P.M., 5P.M., and 8 P.M. for measure-
ment of resultant triglyceride specific activity. The
triglyceride turnover rate was then calculated from
the triglyceride specific activity time curve by a pre-
viously described technique [71. Plasma triglyceride
concentrations measured over the 12-hr period re-
mained stable. Since these studies were carried out
under steady-state conditions, turnover rate = re-
moval rate = production rate. Therefore, hereafter
triglyceride turnover rate will be referred to as tri-
glyceride production rate.
Analytical methods. Blood for glucose, triglycer-
ide, and cholesterol determinations was withdrawn
into tubes containing disodium EDTA. Blood speci-
mens were separated immediately by ultracentrifuga-
tion, and plasma was stored at —20° C. Plasma glu-
cose concentrations were measured by an oxygen
rate modification of the glucose oxidase method
adapted for the Beckman Glucose Analyzer [8]. Im-
munoreactive insulin concentrations were measured
by a modification of the method of Desbuquois and
Aurbach [9]. Plasma triglyceride and cholesterol
concentrations were determined with an autoanaly-
zer (Technicon Methods N-78 and N-24a, respec-
tively). Ideal weights were determined according to
the 1960 Metropolitan Life Tables.
Statistical methods employed included a crossover
design analysis of ratios for comparison of responses
on the two diets and of the areas under the insulin
response curve (the latter included basal values) and
analysis of variance ratio F test.
Results
The study group was composed of 12 males with a
mean (± SEM) age of 54 3 yr (range, 24 to 60 yr).
Mean body weight for the group was 78.0 2 kg
(range, 66.1 to 91.4). Mean relative weight for the
group was 114 2% (range, 101 to 127%). Mean
duration on hemodialysis prior to study was 19 3
months (range, 7 to 42 months). Weights of individ-
ual subjects remained stable during the testing pe-
riod. Controlled dietary intake minimized fluctua-
tions in fluid accumulation between dialyses.
Figure 1 depicts effects of the diets on fasting
plasma triglyceride concentrations for the 12 pa-
tients. Mean values were calculated from an average
of three measurements (made on days 7, 8, and 10)
for each patient. Ten of the 12 patients had fasting
plasma triglycerides above 150 mg/100 ml on the
conventional diet. Fasting plasma triglyceride con-
centrations fell in 11 of 12 patients on either the low-
carbohydrate polyunsaturated fat diet or the low-
carbohydrate saturated fat diet. (Fasting plasma tri-
glyceride concentrations were unchanged by diet in
one patient whose values were below 150 mg/lOO
ml.) The fall in triglyceride concentrations was statis-
tically significant by paired t testing (P < 0.001).
Fasting values for glucose, insulin, and cholesterol
concentrations were similar on all three diets. None
of the patients were hyperglycemic or hyperinsuli-
nemic (normal range for insulin, 2 to 25 U/ml) in the
fasting state. Although both the low-carbohydrate
polyunsaturated fat diet and the low-carbohydrate
saturated fat diet were 15% higher in fat than the
conventional diet, neither resulted in an increase in
postprandial triglyceride concentrations. In fact,
plasma triglycerides were slightly, but not signifi-
cantly lower at each time-point during the meal toler-
ance tests on both of the study diets as compared to
the conventional diet. Finally, it should be noted that
all four patients who received the low-carbohydrate
saturated fat diet had a fall in triglyceride concentra-
tions, and the mean fall in plasma triglycerides was,
if anything, slightly greater (51 10 mg/100 ml) on
the low-carbohydrate saturated fat diet than on the
low carbohydrate polyunsaturated fat diet (42 11
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Fig. 1. Fasting plasma trigyceride concentrations of the 12 indi-
vidual patients on the conventional diet (closed circles) and their
responses to dietary intervention. The bars depict the group
means before and after dietary manipulation. Open circles indicate
patients on the low-carbohydrate polyunsaturated fat (low-CHO
PSF) diet. Arrows and open squares indicate patients on the low-
carbohydrate saturated fat (low-CHO SF) diet.
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mg/100 ml). (With respect to evaluation of peak post-
prandial lipemia, other work in our laboratory has in
fact demonstrated two peaks—the first at 1 to 3 hr
and the second at 4 to 7 hr. Both peaks showed good
correlation with fasting plasma triglyceride concen-
trations. Furthermore, all measurements of post-
prandial triglyceride response correlated well with
each other [6]). Since both study diets led to a fall in
fasting plasma triglycerides, it seems that the most
important component in reduction of plasma triglyc-
eride levels was the decrease in dietary carbohydrate
content.
It is also noteworthy that total cholesterol values
of patients on either of the study diets did not rise
significantly above those values of patients on the
conventional diet. This was also true in undialyzed
subjects in our previously cited work [1]. In fact, in
two patients during the meal tolerance tests, total
cholesterol concentrations were lower with the low-
carbohydrate saturated fat diet than they were with
the conventional diet. Thus, although the kind of fat
might theoretically have been expected to elevate
concentrations of total cholesterol, we did not ob-
serve this effect.
We have previously suggested that there is a sig-
nificant relationship between the plasma insulin re-
sponse elicited by a given diet and the resultant
plasma triglyceride response [10, 111. Thus, it might
be expected that both the low-carbohydrate polyun-
saturated fat diet and the low-carbohydrate saturated
fat diet would be associated with a decreased insulin
response to the noon meal. This expectation is sup-
ported by the data presented in Figure 2, which
indicate that the insulin response to the lunch meal
was lower for patients (P <0.01) on either study diet
than it was on the conventional diet. The decrease in
the insulin response seemed to be approximately the
same for patients ingesting either of the study diets,
and almost certainly reflects the lower carbohydrate
composition of the two diets. These results add fur-
ther support to the association between triglyceride
concentrations and insulin response. Furthermore,
the results are similar to those previously seen in a
group of undialyzed patients with chronic renal fail-
ure [1].
In our earlier study, we also examined the relation-
ship between triglyceride production rate and con-
centration. Results indicated that for a given triglyc-
eride production rate, the triglyceride concentration
was higher than it was in a previously studied group
of normal subjects [1, 7]. The data were therefore
compatible with existence of a removal defect for
very low density lipoproteins in undialyzed subjects
with chronic renal failure. In the present study, we
defined the relationship between triglyceride produc-
tion rate and triglyceride concentration in a group of
nine male patients receiving chronic hemodialysis
and 13 normal male volunteers. These data appear in
Figure 3, in which we have also included the results
of our previous study of undialyzed patients with
chronic renal failure. In all three groups of patients,
the determination of triglyceride production rate was
made after a 10-day period on the conventional diet.
These data appear in the left-hand panel of Figure 3,
and indicate that the highest mean triglyceride pro-
25,000
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Fig. 2. Insulin responses to the Noon meal of the 12 individual
patients on the conventional diet (closed circles) and their re-
sponse to dietary intervention. The bars depict the group means
before and after the dietary manipulation. Open circles indicate
patients on the low-carbohydrate polyunsaturated fat (low-CHO
PSF) diet. Arrows and open squares indicate patients on the low-
carbohydrate saturated fat (low-CHO SF) diet.
Fig. 3. Mean (± SEM) fasting plasma triglyceride production
rates and triglyceride concentrations for the three groups of pa-
tients. Open bars denote control subjects (N = 13); dotted bars
denote patients with chronic renal failure (N = 12); and hatched
bars denote patients on hemodialysis (N = 9).
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duction rate was observed in the control subjects,
with lower values in the patients with renal failure. In
contrast, the results in the right hand panel of Figure
3 demonstrate that mean triglyceride concentrations
are lowest in the control subjects. Furthermore, al-
though mean values for triglycerides were higher in
the undialyzed than they were in the dialyzed pa-
tients, the difference was not significant. These re-
sults indicate that the relationship between triglycer-
ide production rate and concentration is different in
patients with renal failure, and that triglyceride con-
centration will be higher for a given production rate
in these patients as compared to normal individuals.
In order to further analyze this issue, we compared
the slope of the regression line which relates triglyc-
eride production rate to concentration in the three
experimental groups. The slope of the regression line
for both patient groups with renal failure was signifi-
cantly flatter than the slope for the control subjects
was, again suggesting the existence of a defect in the
removal of very low density lipoproteins in patients
with chronic renal failure, i.e., triglyeride concentra-
tions are higher than they are in control patients at a
given triglyceride production rate. Furthermore,
there was no significant difference in the slope of the
regression lines for the two groups of patients with
renal failure, suggesting that the defect in lipoprotein
removal is not corrected by routine three-times-per-
week hemodialysis.
Discussion
We have previously demonstrated that plasma tri-
glyceride concentrations fall in response to modest
dietary manipulation in undialyzed patients with
chronic renal failure [I]. The reduction in fasting
plasma triglycerides was associated with a fall in
triglyceride production rate and a decreased insulin
response to a meal. Although the dietary manipula-
tion involved a decrease in both carbohydrate and
cholesterol content and a relative increase in polyun-
saturated fat, we felt that the most likely explanation
for the results observed was the decrease in dietary
content of carbohydrate [1. 41. Results of the present
study demonstrate that similar dietary modification
can also produce a significant reduction in both fast-
ing plasma triglycerides and postprandial insulin re-
sponses in patients receiving chronic hemodialysis.
Furthermore, the fall in triglyceride concentrations
was achieved regardless of the type of dietary fat
used. Thus, seven of the 12 subjects had a fall in
fasting plasma triglycerides on a diet lower in carbo-
hydrate and cholesterol content and higher in poly-
unsaturated fat than that of the conventional diet. On
the other hand, plasma triglyceride concentrations
also fell in the four patients who ingested a diet lower
in carbohydrate but otherwise identical in composi-
tion to the conventional diet. These results suggest
that the decreased carbohydrate content of the diet is
primarily responsible for the fall in plasma triglycer-
ide concentrations. Moreover, the decrease in carbo-
hydrate content need not be extreme, an important
consideration with respect to patient compliance
when converting formula diet to food in a meal-
planning program [51.
in addition to pointing out that a moderate de-
crease in dietary carbohydrate intake may well lead
to a fall in triglyceride concentration in the majority
of patients with chronic renal failure, these results
also contribute to our understanding of triglyceride
kinetics in these subjects. In order to study this
problem, we compared the relationship between tri-
glyceride production rate and triglyceride concentra-
tion in three groups of patients. As seen in Figure 3,
patients with renal failure (dialyzed and undialyzed)
had triglyceride production rates which were lower
than those of the control patients. At the same time,
their triglyceride concentrations were higher than
those seen in the controls. Taken together, the re-
suits suggest that chronic renal failure leads to a
defect in triglyceride clearance, which does not ap-
pear to be corrected by conventional hemodialysis.
Our data are in keeping with reports of other investi-
gators in this regard [12—141. Since the two groups of
uremic patients, however, consist of different pa-
tients, as opposed to the same patients studied prior
to and after the initiation of hemodialysis, firm con-
clusions cannot be drawn about the ineffectiveness
of dialysis in correcting whatever defect(s) may exist
in patients with uremia. To our knowledge, no evi-
dence is yet available to support a beneficial effect of
conventional dialysis on plasma triglyceride concen-
trations. In this regard, the preliminary results of
Quellhorst, Doht, and Reiger are particularly intrigu-
ing [15]. Treatment of seven patients with hemo-
diafiltration, a new blood-cleansing technique which
removes molecules of much larger molecular weight
than conventional dialysis does, was associated with
a significant fall in fasting plasma triglyceride levels
while serum cholesterol values remain unchanged.
One possible explanation for these findings is the
removal of a molecule, perhaps a protein, which
inhibits the activation of lipoprotein lipase [16, 171.
In conclusion, these results extend our earlier ob-
servation of patients with chronic renal failure prior
to development of end-stage disease and demon-
strate that a moderate reduction in daily carbohy-
drate intake can lead to a fall in plasma triglyceride
concentrations in patients with chronic renal failure.
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This observation is especially relevant since our pre-
viously studied patients had mean creatinine clear-
ance of 19 mllmin, with a range of 7 to 39 [1]. Thus,
some patients would presumably receive medical
management for months to years prior to the neces-
sity for initiating hemodialysis therapy. Since pa-
tients receiving chronic hemodialysis have hypertri-
glyceridemia, which seems to persist with time on
dialysis [18—20], and since hypertriglycendemia may
well be a risk factor for the development of athero-
sclerotic heart disease in patients with normal renal
function [21—24], it seems reasonable to try to lower
triglyceride concentrations. For example, a lipid-
lowering drug, such as clofibrate, could be used for
this purpose. Although a safe method for prescrip-
tion of clofibrate in patients with chronic renal failure
has recently been proposed [251, a variety of compli-
cations have been reported [26—29]. Thus, the rami-
fications of the use of clofib rate in this patient popu-
lation remain unknown at the present time. Our
results show that dietary modification, specifically
with respect to lowering carbohydrate content, is
effective at least on the basis of a short-term study. A
long-term study with a larger group of subjects on a
regular meal diet (as opposed to formula) is needed
to determine the efficacy and safety of this approach
over a period of time. Carefully controlled studies of
this kind may prove of long range value for the large
group of patients currently dependent upon chronic
hemodialysis therapy.
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